Abstract
To assess the current dynamic of an epidemic it is central to collect information on the daily number of newly diseased cases. This is especially important in real-time surveillance, when one aims at evaluating the effects of interventions on disease spread. Reporting delays between disease onset and case reporting hamper our ability to understand the dynamic of an epidemic when looking at the number of daily reported cases only. Nowcasting can be used to adjust daily case counts for occurred-but-not-yet-reported events. Here, we present a novel application of nowcasting to data on the current COVID-19 pandemic in Bavaria. It is based on a hierarchical Bayesian model that considers changes in the reporting delay distribution associated with the week and weekday of reporting and assumes a smooth epidemic curve. Furthermore, we present a way to estimate the time-dependent case reproduction number R(t) based on predictions of the nowcast. We provide methodological details of the developed approach, illustrate results based on data of the current epidemic, discuss limitations and alternative estimation strategies, and provide code for reproduction or adaption of the nowcasting to data from different regions. Results of the nowcasting approach are reported to the Bavarian health authority and published on a webpage on a daily basis.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No external funding was received for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Not applicable.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Code for reproducing our analysis and adapting it to other application scenarios is available at Github. There, we also provide an artificial dataset based on the observed reporting dates of cases but featuring only artificial information on the age and symptom onset dates of the cases.
